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Background
• Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of hospitalizations in older adults, accounting for 726,000 hospitalizations and 1.5 million emergency department visits in the US in year 2000. 1, 2 It is a huge burden for both patients and health care.
• COPD readmissions are not only common but also costly. 3 The Medicare Hospital Readmission Reduction program aims to improve care quality and reduce cost by penalizing hospitals for excessive readmission rates. In 2015, COPD was included in the CMS penalties for 30-day readmissions that originally targeted congestive heart failure, acute myocardial infarction, and pneumonia. 4 • COPD frequently coexists with other conditions known as comorbidities. 5 It is also recognized that COPD comorbidities are a major contributing cause for rehospitalization. 6 Nevertheless, there are limited studies investigating management of multi-diseased COPD patients. The impact of COPD comorbidities in hospital readmissions is still not fully understood.
• There has been considerable inconsistency in the literature regarding risk factors associated with COPD readmission, resulting from variations in study design and adjustment of confounding. 7
Objective
• To explore the prevalence of COPD comorbidities and their impact on 30-day hospital readmission rates in recent years using Electronic Health Record (EHR) Data in order to gain insight on preventing COPD-related re-hospitalizations.
Model Inputs and Data Sources
• COPD patient records from 2009 to 2015 were extracted from a de-identified Cerner Health Facts® EHR database. The ICD-9 codes used to define COPD patients were 491.xx, 492.xx, and 496. 3 Patients from hospitals that were not for acute care or hospitals with no more than 5 beds were excluded.
• Comorbidities of COPD patients were defined according to the Elixhauser algorithms. 8 Overall frequencies of each of the 28 COPD comorbidities as well as the overall distribution of number of comorbidities for each patient were analyzed.
Model Outcomes
• The primary outcome of this study is 30-day all-cause readmission rate for COPD patients. Overall and byyear readmission rates were calculated by dividing the number of 30-day readmissions by the total number of COPD visits included in the study.
Statistical Analysis
• All analyses were carried out using SAS 9.4.
• The associations of COPD comorbidities with 30-day hospital readmission rates were analyzed using chisquared tests (for marginal effect of each comorbidity, data not shown) and three-level generalized linear mixed models.
• The three-level generalized linear mixed model analyzes the effects of each comorbidity or number of comorbidities on 30-day readmission by adjusting for health system (1st level), hospital (2nd level), and hospital and patient (3rd level) demographics such as payer, age, gender, race, number of bed, and year of visit.
• The top 5 COPD comorbidities in prevalence were hypertension (46.2%), diabetes w/o chronic complications (20.0%), fluid and electrolyte disorders (15.0%), deficiency anemia (11.7%), and congestive heart failure (11.0%).
• After adjusting for health systems, hospitals, and demographic factors, all of the 28 comorbidities were found to significantly increase 30-day readmission (P<0.0004 for valvular disease, and P<0.0001 for the others).
• The number of comorbidities had a critical impact on 30-day readmission rates (P<0.0001). The higher the number of comorbidities, the higher the 30-day COPD readmission rate.
• COPD comorbidities significantly affect 30-day hospital readmission rates; therefore, effectively managing these comorbidities is essential for reducing COPD-related re-hospitalizations.
• The fact that hospital readmission rates have been markedly decreasing in recent years is encouraging.
• Detailed analysis of the EHR readmission data may help to evaluate the efficiency of health care management and prevent hospital readmission penalties.
